Abstract: Systems and methods for identifying shareable airborne radar spectrum are disclosed. The system may include an Airborne Radar Sensing Capability (AR-SC) system that performs a method including: receiving, from a sensor, information indicative of an active airborne radar, the information comprising at least: an identification of the sensor; determining one or more frequencies affected by the active airborne radar; and determining whether the active airborne radar is associated with a specific aircraft; if the active airborne radar is associated with a specific aircraft: determining a location of the aircraft; and reporting, to a spectrum controller, (i) the one or more affected frequencies, and (ii) the location of the aircraft; if the active airborne radar is not associated with a specific aircraft: reporting, to a spectrum controller, the one or more affected frequencies.

Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.

Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.

Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.

Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.

Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.

Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.

Abstract: A system and computerized method for controlling access to shared spectrum in which access is prioritized among different classes of devices so that top priority devices have immediate access to the shared spectrum and lower priority devices contend for access. In some embodiments, the system and computerized method comprises managing a set of priority classes of devices to use the shared spectrum and granting rights to one or more of the requesting devices to use a portion of the shared spectrum during a requested use period based on a decision making process.

Abstract: Disclosed are compounds of Formula (I) or a salt thereof; wherein: X is N or CH; Q1 is: (i) Cl, Br, I, —CN, —CH3, or —CF3; (ii) a 5-membered heteroaryl selected from pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, thiazolyl, triazolyl, oxadiazolyl, and thiadiazolyl; (iii) a 6?membered heteroaryl selected from pyridinyl, pyridazinyl, and pyrimidinyl; or (iv) a bicyclic heteroaryl selected from indolyl, pyrrolopyridinyl, pyrazolopyridinyl and benzo[d]oxazolyl; wherein each of said 5-membered, 6-membered, and bicyclic heteroaryl is substituted with zero to 1 Ra and zero to 1 Rb; and R1, R2, R3, R4, R5, R6, Ra, and Rb are defined herein. Also disclosed are methods of using such compounds as modulators of PI3K, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing inflammatory and autoimmune diseases.

Abstract: A system and computerized method for controlling access to shared spectrum in which access is prioritized among different classes of devices so that top priority devices have immediate access to the shared spectrum and lower priority devices contend for access. In some embodiments, the system and computerized method comprises managing a set of priority classes of devices to use the shared spectrum and granting rights to one or more of the requesting devices to use a portion of the shared spectrum during a requested use period based on a decision making process.

Abstract: An improved system architecture for making spectrum information available to one or more devices and for providing and using the spectrum information at a device. The improved architecture employs an arrangement of software processes that interact to provide a flexible and highly-configurable technique for controlling access to spectrum information. To that end, a spectrum information server executes a server process having a library of spectrum-related functions including, for example, functions for retrieving spectrum data from spectrum data sources and/or for processing retrieved spectrum data. The spectrum information server also executes one or more device host processes configured to communicate with at least one compatible device process executing on a spectrum-aware (SA) device. In an illustrative embodiment, a device process on the SA device may request spectrum information from a device host process on the spectrum information server.

Abstract: Disclosed are compounds of Formula (I) or a salt thereof; wherein: X is N or CH; Q1 is: (i) Cl, Br, I, —CN, —CH3, or —CF3; (ii) a 5-membered heteroaryl selected from pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, thiazolyl, triazolyl, oxadiazolyl, and thiadiazolyl; (iii) a 6?membered heteroaryl selected from pyridinyl, pyridazinyl, and pyrimidinyl; or (iv) a bicyclic heteroaryl selected from indolyl, pyrrolopyridinyl, pyrazolopyridinyl and benzo[d]oxazolyl; wherein each of said 5-membered, 6-membered, and bicyclic heteroaryl is substituted with zero to 1 Ra and zero to 1 Rb; and R1, R2, R3, R4, R5, R6, Ra, and Rb are defined herein. Also disclosed are methods of using such compounds as modulators of PI3K, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing inflammatory and autoimmune diseases.

Abstract: An improved system architecture for making spectrum information available to one or more devices and for providing and using the spectrum information at a device. The improved architecture employs an arrangement of software processes that interact to provide a flexible and highly-configurable technique for controlling access to spectrum information. To that end, a spectrum information server executes a server process having a library of spectrum-related functions including, for example, functions for retrieving spectrum data from spectrum data sources and/or for processing retrieved spectrum data. The spectrum information server also executes one or more device host processes configured to communicate with at least one compatible device process executing on a spectrum-aware (SA) device. In an illustrative embodiment, a device process on the SA device may request spectrum information from a device host process on the spectrum information server.

Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.

Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.

Abstract: The present invention provides compounds of Formula (I): (I), as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicaments.

Abstract: A compound of formula I wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.

Abstract: A system and computerized method for controlling access to shared spectrum in which access is prioritized among different classes of devices so that top priority devices have immediate access to the shared spectrum and lower priority devices contend for access. In some embodiments, the system and computerized method comprises managing a set of priority classes of devices to use the shared spectrum and granting rights to one or more of the requesting devices to use a portion of the shared spectrum during a requested use period based on a decision making process.

Abstract: The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicaments.

Abstract: The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicaments.